Novel hydroxyapatite-targeting nanodrug may be a paradigm shift for cancer treatment

A multidisciplinary research team at Vanderbilt University and Vanderbilt University Medical Center has discovered a new way to kill a tumor by disrupting its acidic "microenvironment" without harming normal tissue.